These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Factors Associated with Delta-8 THC Retail Availability in Fort Worth, Texas, 2021-2022. LoParco CR; Kong AY; Yockey RA; Sekhon V; Olsson S; Rossheim ME Subst Use Misuse; 2024; 59(6):840-846. PubMed ID: 38247162 [No Abstract] [Full Text] [Related]
5. Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol. Abdel-Kader MS; Radwan MM; Metwaly AM; Eissa IH; Hazekamp A; ElSohly MA Molecules; 2024 Mar; 29(6):. PubMed ID: 38542886 [No Abstract] [Full Text] [Related]
6. The Dark Side of Cannabidiol: The Unanticipated Social and Clinical Implications of Synthetic Δ Geci M; Scialdone M; Tishler J Cannabis Cannabinoid Res; 2023 Apr; 8(2):270-282. PubMed ID: 36264171 [No Abstract] [Full Text] [Related]
7. Public interest in ∆ Leas EC; Nobles AL; Shi Y; Hendrickson E Int J Drug Policy; 2022 Mar; 101():103557. PubMed ID: 34952279 [TBL] [Abstract][Full Text] [Related]
8. Delta-8, Delta-10, HHC, THC-O, THCP, and THCV: What Should We Call These Products? Rossheim ME; LoParco CR; Henry D; Trangenstein PJ; Walters ST J Stud Alcohol Drugs; 2023 May; 84(3):357-360. PubMed ID: 36971760 [TBL] [Abstract][Full Text] [Related]
9. How Are Retailers Describing Delta-8 THC?A Mixed-Methods Study in Fort Worth, Texas. LoParco CR; Olsson SE; Greene KM; Livingston MD; Henry D; Trangenstein PJ; Walker A; Rossheim ME J Stud Alcohol Drugs; 2023 Mar; 84(2):298-302. PubMed ID: 36971730 [TBL] [Abstract][Full Text] [Related]
10. Using Transformer-Based Topic Modeling to Examine Discussions of Delta-8 Tetrahydrocannabinol: Content Analysis. Smith BP; Hoots B; DePadilla L; Roehler DR; Holland KM; Bowen DA; Sumner SA J Med Internet Res; 2023 Dec; 25():e49469. PubMed ID: 38127427 [TBL] [Abstract][Full Text] [Related]
11. Delta-8 THC use in US adults: Sociodemographic characteristics and correlates. Livne O; Budney A; Borodovsky J; Walsh C; Shmulewitz D; Fink DS; Struble CA; Habib M; Aharonovich E; Hasin DS Addict Behav; 2022 Oct; 133():107374. PubMed ID: 35644057 [TBL] [Abstract][Full Text] [Related]
12. Patterns of delta 8 THC and cannabis uptake in Nebraska: A cannabis prohibition state. Humeniuk R; Habecker P; Cooper-Ohm S; Bevins RA Int J Drug Policy; 2024 May; 127():104400. PubMed ID: 38554564 [TBL] [Abstract][Full Text] [Related]
13. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores. Spindle TR; Sholler DJ; Cone EJ; Murphy TP; ElSohly M; Winecker RE; Flegel RR; Bonn-Miller MO; Vandrey R JAMA Netw Open; 2022 Jul; 5(7):e2223019. PubMed ID: 35857320 [TBL] [Abstract][Full Text] [Related]
14. Reported exposures to derived cannabis products in California before and after the 2018 federal reclassification of hemp. Madan K; Schmidt S; Chami RF; Ho R; Lewis JC; Apollonio DE Int J Drug Policy; 2024 Feb; 124():104313. PubMed ID: 38194724 [TBL] [Abstract][Full Text] [Related]
15. THC and CBD: Villain versus Hero? Insights into Adolescent Exposure. Pintori N; Caria F; De Luca MA; Miliano C Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982327 [TBL] [Abstract][Full Text] [Related]
16. Derived psychoactive cannabis products and 4/20 specials: An assessment of popular brands and retail price discounts in Fort Worth, Texas, 2023. Rossheim ME; LoParco CR; Berg CJ; Tillett KK; Trangenstein PJ; Henry D; Yockey RA; Livingston MD; Jernigan DH; Sussman SY Drug Alcohol Depend; 2024 Mar; 256():111119. PubMed ID: 38350186 [TBL] [Abstract][Full Text] [Related]
17. Popularity of Delta-8 THC on the Internet Across US States, 2021. Livingston MD; Walker A; Cannell MB; Rossheim ME Am J Public Health; 2022 Feb; 112(2):296-299. PubMed ID: 35080939 [No Abstract] [Full Text] [Related]
18. Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC. Kruger DJ; Kruger JS Cannabis Cannabinoid Res; 2023 Feb; 8(1):166-173. PubMed ID: 34797727 [No Abstract] [Full Text] [Related]
19. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity? Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047 [TBL] [Abstract][Full Text] [Related]
20. Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies. De Aquino JP; Bahji A; Gómez O; Sofuoglu M Drug Alcohol Depend; 2022 Dec; 241():109702. PubMed ID: 36434879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]